Pathogenesis, Diagnosis and treatment of lysosomal diseases by Biomarker Analysis
Project/Area Number |
17K10067
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Southen Tohoku Research Institute for Neuroscience |
Principal Investigator |
Eto Yoshikatsu 一般財団法人脳神経疾患研究所, 先端医療研究センター, センター長 (50056909)
|
Co-Investigator(Kenkyū-buntansha) |
WU CHEN 一般財団法人脳神経疾患研究所, 先端医療研究センター, 研究員 (90790840)
HOSSAIN ARIF 一般財団法人脳神経疾患研究所, 先端医療研究センター, 研究員 (40777893)
柳澤 比呂子 一般財団法人脳神経疾患研究所, 先端医療研究センター, 研究員 (60416659)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | ライソゾーム病 / NPC / ファブリ病 / バイオマーカー / オキシステロール、 / iPS細胞 / タンデムMS / Niemann-Pick C病 / 蓄積脂質 / lysoGb3 / oxysterol / TEM解析 / ゴーシェ病 / ニーマンピック病 / iPS細胞作製 / プロテオミクス / NPC病 / iPS cells / MS/MS / lysosomal disease |
Outline of Final Research Achievements |
Among various lysosomal diseases,we studied Niemann-Pick C(NPC)disease to measure plasma biomarkers such as oxysterol 7KC,lysosphingomyelin and bile acid 506 measured by tandem MS.We also generated iPS cells of NPC patients by Sendai virus and differentiated into neuroprogenitor cells/neuron and examined their relationship with their pathological conditions studied by electron microscopy and also determination of various biomarkers including lipids and proteome analysis in neuroprogenitor cells and mature neurons by tandem MS.Our data including lipid anlaysis and proteome analysis in these neural progenitor cells derived from NPC iPS cells by tandem MS indicated that 6 proteins in NPC progenitor cells were increased, specifically and may related to abnormal proteome metabolism in NPC neuronal cells.Furthermore, treatment by various candidate compounds may change these abnormal metabolism in neural cells derived from NPC iPS cells.
|
Academic Significance and Societal Importance of the Research Achievements |
ライソゾーム病の内ニーマンピツクC(NPC)病の各種血清バイオマーカーをタンデムMSで測定することにより患者の早期診断をし、治療に結びつけることが可能である。又NPC iPS細胞から神経細胞などへの分化研究により、NPCの神経障害の メカニズムをNPCiPSから分化した神経幹細胞の脂質代謝並びにプロテオゾーム解析をタンデムマスで一斉分析を行い、細胞内での脂質並びにプロテオミクスの異常を明らかにすることが出来た。今後神経細胞の治療に伴う、プロテオミクス効果を確認することが可能になり、病態解明と共に治療効果を明らかにすることができる。
|
Report
(4 results)
Research Products
(43 results)
-
-
-
-
[Journal Article] Phenotypic variability of Niemann-Pick disease type C including a case with clinically pure schizophrenia: a case report.2018
Author(s)
1.Kawazoe T, Yamamoto T, Narita A, Ohno K, Adachi K, Nanba E, Noguchi A, Takahashi T, Maekawa M, Eto Y, Ogawa M, Murata M, Takahashi Y. Phenotypic variability of Niemann-Pick disease type C including a case with clinically pure schizophrenia: a case report. BMC Neurol. 2018 Aug 17;18(1):117.
-
Journal Title
BMC Neurol.
Volume: 2018 Aug 1718(1)
Pages: 117-117
Related Report
-
-
[Journal Article] The beneficial effects of long-term enzyme replacement therapy on cardiac involvement in Japanese Fabry patients.2018
Author(s)
3.Hongo K, Ito K, Date T, Anan I, Inoue Y, Morimoto S, Ogawa K, Kawai M, Kobayashi H, Kobayashi M, Ida H, Ohashi T, Taniguchi I, Yoshimura M, Eto Y.
-
Journal Title
Mol Genet Metab.
Volume: 2018 Jun;124(2)
Pages: 143-151
Related Report
-
[Journal Article] P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.2018
Author(s)
4.Kobayashi H, Ariga M, Sato Y, Fujiwara M, Fukasawa N, Fukuda T, Takahashi H, Ikegami M, Kosuga M, Okuyama T, Eto Y, Ida H.
-
Journal Title
JIMD Rep.
Volume: 2018;41
Pages: 101-107
Related Report
-
[Journal Article] Characteristics of PPT1 and TPP1 enzymes in neuronal ceroid lipofuscinosis (NCL) 1 and 2 by dried blood spots (DBS) and leukocytes and their application to newborn screening.2018
Author(s)
5.Itagaki R, Endo M, Yanagisawa H, Hossain MA, Akiyama K, Yaginuma K, Miyajima T, Wu C, Iwamoto T, Igarashi J, Kobayashi Y, Tohyama J, Iwama K, Matsumoto N, Shintaku H, Eto Y.
-
Journal Title
Mol Genet Metab.
Volume: 2018 May;124(1)
Pages: 64-70
Related Report
-
[Journal Article] Characteristics of PPT1 and TPP1 enzymes in neuronal ceroid lipofuscinosis (NCL) 1 and 2 by dried blood spots (DBS) and leukocytes and their application to newborn screening.2018
Author(s)
Itagaki R, Endo M, Yanagisawa H, Hossain MA, Akiyama K, Yaginuma K, Miyajima T, Wu C, Iwamoto T, Igarashi J, Kobayashi Y, Tohyama J, Iwama K, Matsumoto N, Shintaku H, Eto Y.
-
Journal Title
Mol Genet Metab.
Volume: S1096-7192(18)
Issue: 1
Pages: 30154-9
DOI
Related Report
Peer Reviewed
-
[Journal Article] The severe clinical phenotype for a heterozygous Fabry female patient correlates to the methylation of non-mutated allele associated with chromosome 10q26 deletion syndrome.2017
Author(s)
Hossain MA, Yanagisawa H, Miyajima T, Wu C, Takamura A, Akiyama K, Itagaki R, Eto K, Iwamoto T, Yokoi T, Kurosawa K, Numabe H, Eto Y.
-
Journal Title
Molecular Genetics and Metabolism
Volume: 120
Issue: 3
Pages: 173-179
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] L-leucine and SPNS1 coordinately ameliorate dysfunction of autophagy in mouse and human Niemann-Pick type C disease.2017
Author(s)
Yanagisawa H, Ishii T, Endo K, Kawakami E, Nagao K, Miyashita T, Akiyama K, Watabe K, Komatsu M, Yamamoto D, Eto Y.
-
Journal Title
Sci Rep
Volume: 7
Issue: 1
Pages: 15994-15994
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
[Presentation] ○ ウーチェン 1,2,3, 岩本 武夫 4, ホセイン モハンマドアリフ 1,3, 宮島 任司 1,2, 秋山けい子 1 柳澤比呂子 1, 五十嵐純子 2, 衛藤 義勝 3 1 一般財団法人脳神経疾患研究所先端医療研究センター, 2 アンジェス株式会社希少疾患研究所 3 東京慈恵医科大学, 4 東京慈恵会医科大学総合医科学研究センター基盤研究施設(分子細胞生物学)2018
-
[Presentation] ○ 板垣 里奈 1, 岩本 武夫 3, ホサイン モハンマド アリフ 1, 柳澤比呂子 1, 宮島 任司 1,2 ウ チェン 1,2, 秋山けい子 1, 新宅 治夫 4, 衛藤 義勝 1 1 先端医療研究センター & 遺伝病治療研究所, 2 アンジェス株式会社 希少疾患研究所 3 東京慈恵会医科大学 総合医科学研究センター基盤研究施設 4 大阪市立大学大学院医学研究科2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-